Drug Report History #99733

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v1-EN
Language English English
Date Updated (Changed) Updated to: 2020-01-04 Was: 2019-11-27
Drug Identification Number 02443538 02443538
Brand name TARO-TEMOZOLOMIDE TARO-TEMOZOLOMIDE
Common or Proper name TARO-TEMOZOLOMIDE TARO-TEMOZOLOMIDE
Company Name TARO PHARMACEUTICALS INC TARO PHARMACEUTICALS INC
Ingredients TEMOZOLOMIDE TEMOZOLOMIDE
Strength(s) 140MG 140MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 5 blister 5 blister
Additional packaging sizes
ATC code L01AX L01AX
ATC description ALKYLATINGAGENTS ALKYLATINGAGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-11-18 2019-11-18
Estimated end date (Changed) Updated to: 2020-01-31 Was: 2019-12-20
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments